Aureus Licenses AurSCOPE® GPCR to Euroscreen
News Oct 07, 2005
Aureus Pharma has announced that Euroscreen, SA has become a customer of its AurSCOPE GPCR knowledge database.
AurSCOPE GPCR is designed to provide researchers rapid access to quantitative biological activity data mined from the scientific journals and patents for all known GPCR's, a major class of membrane proteins.
Euroscreen will use Aureus Pharma's technology in conjunction with their in-house technology to identify GPCR drug candidates.
“By integrating the Aureus GPCR knowledge database with Euroscreen's research platform, our scientists will be able to rapidly prioritize candidates in lead generation and optimization programs,” said Dr. Francois Roman, Vice President R & D for Euroscreen.
“The information contained within the database will also help us in the design of our chemical libraries for our screening campaigns,” said Dr. Frederic Ooms, Head of Chemistry for Euroscreen.
“As Euroscreen is a world leader in GPCR research, we are pleased they have adopted our AurSCOPE GPCR knowledge base,” said Dr. Andre Michel, CEO of Aureus Pharma.
“AurSCOPE GPCR with its high quality biological and chemical information will complement Euroscreen's technology resulting in an overall acceleration of the discovery process.”
Researchers at the Crick and Imperial College London have generated malaria parasites resistant to a promising new class of candidate antimalarial drugs. By analyzing the structural changes behind the resistance, they identified novel compounds that were immune to this mechanism of resistance.READ MORE